These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24372240)

  • 1. Design, virtual screening and docking study of novel NS3 inhibitors by targeting protein-protein interacting sites of dengue virus - a novel approach.
    Parida P; Yadav RN; Sarma K; Nainwal LM
    Curr Pharm Biotechnol; 2013; 14(11):995-1008. PubMed ID: 24372240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insight into structural organization and protein-protein interaction of non structural 3 (NS3) proteins from dengue serotypes.
    Parida P; Yadav RN; Sarma K
    Curr Pharm Biotechnol; 2014; 15(2):156-72. PubMed ID: 24910013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Insights into the Molecular Interaction of a Panduratin A Derivative with the Non Structural Protein (NS3) of Dengue Serotypes: A Molecular Dynamics Study.
    Parida P; Yadav RNS; Dehury B; Ghosh D; Mahapatra N; Mitra A; Mohanta TK
    Curr Pharm Biotechnol; 2017; 18(9):769-782. PubMed ID: 29173158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico evaluation of inhibitory potential of triterpenoids from Azadirachta indica against therapeutic target of dengue virus, NS2B-NS3 protease.
    Dwivedi VD; Tripathi IP; Mishra SK
    J Vector Borne Dis; 2016; 53(2):156-61. PubMed ID: 27353586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3D-QSAR pharmacophore-based virtual screening, molecular docking and molecular dynamics simulation toward identifying lead compounds for NS2B-NS3 protease inhibitors.
    Luo PH; Zhang XR; Huang L; Yuan L; Zhou XZ; Gao X; Li LS
    J Recept Signal Transduct Res; 2017 Oct; 37(5):481-492. PubMed ID: 28758854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of potential inhibitors for HCV NS3 genotype 4a by combining protein-ligand interaction fingerprint, 3D pharmacophore, docking, and dynamic simulation.
    El-Hasab MAE; El-Bastawissy EE; El-Moselhy TF
    J Biomol Struct Dyn; 2018 May; 36(7):1713-1727. PubMed ID: 28531373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and docking studies of peptide inhibitors as potential antiviral drugs for dengue virus ns2b/ns3 protease.
    Velmurugan D; Mythily U; Rao K
    Protein Pept Lett; 2014; 21(8):815-27. PubMed ID: 23855663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-guided Discovery of a Novel Non-peptide Inhibitor of Dengue Virus NS2B-NS3 Protease.
    Li L; Basavannacharya C; Chan KW; Shang L; Vasudevan SG; Yin Z
    Chem Biol Drug Des; 2015 Sep; 86(3):255-64. PubMed ID: 25533891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel inhibitor of dengue virus protease through use of a virtual screening drug discovery Web portal.
    Viswanathan U; Tomlinson SM; Fonner JM; Mock SA; Watowich SJ
    J Chem Inf Model; 2014 Oct; 54(10):2816-25. PubMed ID: 25263519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping the Interactions between the NS4B and NS3 proteins of dengue virus.
    Zou J; Lee le T; Wang QY; Xie X; Lu S; Yau YH; Yuan Z; Geifman Shochat S; Kang C; Lescar J; Shi PY
    J Virol; 2015 Apr; 89(7):3471-83. PubMed ID: 25589636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of new competitive dengue NS2B/NS3 protease inhibitors-a computational approach.
    Frimayanti N; Chee CF; Zain SM; Rahman NA
    Int J Mol Sci; 2011 Feb; 12(2):1089-100. PubMed ID: 21541045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovering key residues of dengue virus NS2b-NS3-protease: New binding sites for antiviral inhibitors design.
    Aguilera-Pesantes D; Robayo LE; Méndez PE; Mollocana D; Marrero-Ponce Y; Torres FJ; Méndez MA
    Biochem Biophys Res Commun; 2017 Oct; 492(4):631-642. PubMed ID: 28343993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virtual ligand screening of the National Cancer Institute (NCI) compound library leads to the allosteric inhibitory scaffolds of the West Nile Virus NS3 proteinase.
    Shiryaev SA; Cheltsov AV; Gawlik K; Ratnikov BI; Strongin AY
    Assay Drug Dev Technol; 2011 Feb; 9(1):69-78. PubMed ID: 21050032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-silico identification and evaluation of plant flavonoids as dengue NS2B/NS3 protease inhibitors using molecular docking and simulation approach.
    Qamar MT; Ashfaq UA; Tusleem K; Mumtaz A; Tariq Q; Goheer A; Ahmed B
    Pak J Pharm Sci; 2017 Nov; 30(6):2119-2137. PubMed ID: 29175781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Combined Genetic-Proteomic Approach Identifies Residues within Dengue Virus NS4B Critical for Interaction with NS3 and Viral Replication.
    Chatel-Chaix L; Fischl W; Scaturro P; Cortese M; Kallis S; Bartenschlager M; Fischer B; Bartenschlager R
    J Virol; 2015 Jul; 89(14):7170-86. PubMed ID: 25926641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of novel small molecule inhibitors of dengue viral NS2B-NS3 protease using virtual screening and scaffold hopping.
    Deng J; Li N; Liu H; Zuo Z; Liew OW; Xu W; Chen G; Tong X; Tang W; Zhu J; Zuo J; Jiang H; Yang CG; Li J; Zhu W
    J Med Chem; 2012 Jul; 55(14):6278-93. PubMed ID: 22742496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virtual screening of eighteen million compounds against dengue virus: Combined molecular docking and molecular dynamics simulations study.
    Mirza SB; Salmas RE; Fatmi MQ; Durdagi S
    J Mol Graph Model; 2016 May; 66():99-107. PubMed ID: 27054972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and SAR studies of methionine-proline anilides as dengue virus NS2B-NS3 protease inhibitors.
    Zhou GC; Weng Z; Shao X; Liu F; Nie X; Liu J; Wang D; Wang C; Guo K
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6549-54. PubMed ID: 24268549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of dengue virus protease expression plasmid and in vitro protease assay for screening antiviral inhibitors.
    Lai H; Teramoto T; Padmanabhan R
    Methods Mol Biol; 2014; 1138():345-60. PubMed ID: 24696347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The non-structural 3 (NS3) protein of dengue virus type 2 interacts with human nuclear receptor binding protein and is associated with alterations in membrane structure.
    Chua JJ; Ng MM; Chow VT
    Virus Res; 2004 Jun; 102(2):151-63. PubMed ID: 15084397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.